Brinker International, Inc. To Host First Quarter Fiscal 2018 Earnings Call
Global Cell-based Assays Technologies and Markets, 2015-2017 & 2021
New Study Underscores The Safety Of Autologous Stem Cell Therapy In Degenerative Diseases And Injuries
3D Cell Cultures Markets, 2030
U.S. Stem Cell, Inc. CSO to Present at Bulletproof Biohacking Conference on October 13th in Pasadena, CA
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
International Stem Cell Corporation Developed 3D Bioprinting Technology Targeted to Treat Liver Diseases
International Stem Cell Corporation to Expand its Revenue Generating Biomedical Businesses to Support Ongoing and Future Clinical Trials
Stem Cells Market to reach US$270.5 bn by 2025, globally: Transparency Market Research
International Stem Cell Corporation to Move Forward with Traumatic Brain Injury Phase II Clinical Trial
 51   52   53   54   55     56    57   58   59   60   61 
 <<   <   >   >>